Literature DB >> 12379428

Astaxanthin and canthaxanthin do not induce liver or kidney xenobiotic-metabolizing enzymes in rainbow trout (Oncorhynchus mykiss Walbaum).

G I Page1, S J Davies.   

Abstract

This study was designed to assess the effects of dietary carotenoid supplementation on liver and kidney xenobiotic-metabolizing enzymes in the rainbow trout. Twelve rainbow trout (mean weight 266+/-10 g) were assigned to each of three replicate tanks for each of four dietary treatments; astaxanthin, canthaxanthin, negative control and positive control using beta-naphthoflavone, at a target dietary inclusion of 100 mg kg(-1) for each additive. Fish were fed for 3 weeks at a level of 1.2% body wt. day(-1). Serum carotenoid levels were used as indicators of exposure and were not significantly different (P>0.05) between carotenoid-fed trout. Livers and kidney were frozen separately in liquid N(2) by immersion and microsomal fractions from pooled samples (n=3) assayed for xenobiotic-metabolizing enzyme (cytochrome P450 monoxygenase) activities including ethoxyresorufin O-deethylase; methoxyresorufin O-demethylase; pentoxyresorufin O-dealkylase; benzoxyresorufin O-dearylase; and the conjugating enzymes glucuronosyl transferase; and glutathione-s-transferase. Results revealed that carotenoid treatment did not significantly (P>0.05) induce any enzyme system examined. Results are discussed in the context of metabolism of absorbed carotenoids.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379428     DOI: 10.1016/s1532-0456(02)00168-0

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Toxicol Pharmacol        ISSN: 1532-0456            Impact factor:   3.228


  2 in total

Review 1.  Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review.

Authors:  Ranga Rao Ambati; Siew Moi Phang; Sarada Ravi; Ravishankar Gokare Aswathanarayana
Journal:  Mar Drugs       Date:  2014-01-07       Impact factor: 5.118

Review 2.  Molecular Mechanisms of Astaxanthin as a Potential Neurotherapeutic Agent.

Authors:  Eshak I Bahbah; Sherief Ghozy; Mohamed S Attia; Ahmed Negida; Talha Bin Emran; Saikat Mitra; Ghadeer M Albadrani; Mohamed M Abdel-Daim; Md Sahab Uddin; Jesus Simal-Gandara
Journal:  Mar Drugs       Date:  2021-04-03       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.